Literature DB >> 7223616

Oral vasodilator therapy with prazosin in severe congestive heart failure.

N A Awan, D T Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7223616     DOI： 10.1016/0002-8703(81)90250-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

1.  Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.

Authors:  J Vincent; W Dachman; T F Blaschke; B B Hoffman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.

Authors:  J Bayliss; R Canepa-Anson; M S Norell; P Poole-Wilson; G Sutton
Journal:  Br Heart J       Date:  1986-03

3.  Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Authors:  J Bayliss; M S Norell; R Canepa-Anson; C Reid; P Poole-Wilson; G Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

Review 4.  Vasodilator therapy in chronic congestive heart failure.

Authors:  A B Schwartz; K Chatterjee
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

5.  Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure.

Authors:  N P Wilkes; E Barin; R Hoschl; G S Stokes; G I Nelson
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 6.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.